Jeannette Bannink

MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Gabriela Hernández‐Hoyos, Toddy Sewell, Robert Bader et al. · Molecular Cancer Therapeutics · 2016 · 71 citations · Full text

Medicine, Immunology, Oncology +17

Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumor

Teresa M. Foy, Jeannette Bannink, Robert A Sutherland et al. · Vaccine · 2001 · 55 citations

Medicine, Immunology, Oncology +16

Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: A phase I, open-label, dose-escalation clinical study

Daniel Burge, S. Bookbinder, Alan Kivitz et al. · Clinical Therapeutics · 2008 · 28 citations

Medicine, Pharmacokinetics, Pharmacology +16

Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4⁺ cell depletion in <i>Macaca nemestrina</i>

Janela McClure, Ann Marie Schmidt, Marie-Anne Rey-Cuillé et al. · Journal of Medical Primatology · 2000 · 27 citations

Life Sciences, Immunology, Infectious Diseases +17

Abstract LB-199: APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity with limited cytokine release, is well tolerated in repeat dose toxicology studies in cynomolgus macaques

Michael R. Comeau, Rebecca Gottschalk, Mollie Daugherty et al. · Cancer Research · 2019 · 10 citations

Life Sciences, Immunology, Oncology +16